Four clinical trials in Canada involving the cancer treatment medication Zydelig (generic: idelalisib) have been halted following international reports of “an increased rate of serious adverse events, including deaths,” according to a statement by Health Canada.
Free Confidential Lawsuit Evaluation: If you were injured by Zydelig side effects, or a loved one died after being treated with the drug, you should contact our law firm immediately. You may be entitled to compensation by filing a suit against the manufacturer and our lawyers can help.
What’s the Problem?
March 18, 2016 – In addition to canceling the 4 clinical trials involving Zydelig in combination with other cancer treatment drugs, Health Canada will amend another 3 trials by instituting protective measures to ensure patient safety.
Health Canada said it would also conduct a review of Zydelig. At least one patient death was associated with the drug in a clinical trial performed in Australia.
Health Canada approved Zydelig in April 2015 for the treatment of a rare blood cancer known as relapsed chronic lymphocytic leukemia, although the recently halted clinical studies were looking at “patients with different disease characteristics or using different drug combinations for what Zydelig is currently approved for in Canada.”
“The trial sponsor has communicated the new safety issues to Canadian trial site investigators,” Health Canada said. “Patients enrolled in clinical trials using Zydelig should speak with their physician.”
Do I Have a Zydelig Lawsuit?
The Pharmaceutical Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Zydelig lawsuits. We are handling individual litigation nationwide and currently accepting new injury and death cases in all 50 states.
Free Confidential Case Evaluation: Again, if you were harmed by Zydelig, you should contact our law firm immediately. You may be entitled to a settlement by filing a lawsuit and we can help.